(888) 391-1315



New Reports Question Safety of IVC Blood Clot Filters As Lawsuits Mount

Wednesday, October 19, 2016

Amid recent questions over the safety of Inferior Vena Cava blood clot filters, two new reports warn of their immanent dangers and a federal judicial panel has disclosed a surge in lawsuits filed by injured patients.

Inferior Vena Cava (IVC) filters are tiny, metal vein implants that catch blood clots before they reach the heart or lungs. They are generally used in emergencies or for those who can’t take blood thinners. Each year, they are used in around 250,000 patients.

Read More

DrugNews' Weekly FDA Recall & Warning Report for September 29, 2016

Friday, September 30, 2016

This week, DrugNews highlights eight recalls announced by the U.S. Food and Drug Administration during the month of September. Seven of these involved food products while one dealt with a line of injectable drugs.

Below you will find more information on the recalls, and what consumers need to know for their safety.

Read More

Victims Ask to Consolidate Invokana Kidney Lawsuits as New Data Raises Questions

Monday, September 26, 2016

Amid mounting FDA warnings that the diabetes drug Invokana may cause kidney damage, a new study out last month confused the issue by suggesting the drug may actually slow kidney damage.

The data comes as the growing number of lawsuits against the manufacturer of Invokana, Johnson & Johnson, has led to victims requesting that cases be consolidated to a central federal court for quicker handling.

Read More

Will Xarelto, Eliquis Antidote Come in Time to Save Thousands?

Thursday, September 15, 2016

Last month DrugNews reported that the FDA had delayed approval of an antidote for new age blood thinning drugs Eliquis and Xarelto due to questions with the manufacturing process.

Now, as the number of patients injured or killed by uncontrollable internal bleeding continues to rise, new data suggests the experimental antidote could help save as many as 90% of them from the risk.

Read More

DrugNews' Mid-August FDA Recall & Warning Recap

Wednesday, August 24, 2016

In this week’s installment of the DrugNews FDA Recall & Warning Recap, we look at eight actions taken by the agency over the past week. These ranged from simple food-based allergies to bacterial presence to lead contamination in foods.

Here is more information on the most recent recalls and what consumers should know.

Read More

New Studies Announced to Compare All Blood Thinner Drugs for First Time

Tuesday, August 16, 2016

A leading research institute recently announced funding that will support two new studies into the safety and effectiveness of new anticoagulant drugs – the first of their kind to compare all drugs currently available.

The move was announced last month by the Patient-Centered Outcomes Research Institute, which will commit $6.5 million in funding for the studies. They will be carried out by teams at the University of California at San Francisco and Brigham and Womens Hospital in Boston.

Read More

DrugNews' Weekly FDA Recalls & Warnings Recap - August 1, 2016

Thursday, August 04, 2016

Last week was a busy week for recalls at the FDA, with 13 total recalls on consumer foods and medical products. These ranged from simple food-based allergies to full-blown bacterial contamination and metal fragments in foods.

Here is more information on these recalls and what you should know as a consumer.

Read More

New Report Warns of Increasing SGLT2 & Invokana Risks

Thursday, August 04, 2016

A new class of diabetes drugs known as SGLT2 inhibitors has seen tremendous growth over the past few years. However, a leading consumer safety organization recently issued a troubling report uncovering a multitude of side effect concerns.

SGLT2 inhibitors are prescribed to patients with type 2 diabetes. They essentially make the kidneys excrete blood sugar and sodium instead of absorbing them.

Read More

ISMP Ranks Xarelto Most Dangerous Drug in the United States

Thursday, July 28, 2016

The joint-effort oral anticoagulant Xarelto from Bayer and Johnson & Johnson has seen stellar growth this past year in both sales and approved uses. With nearly 7 million prescriptions now written each year, it dwarfs nearest competitors Eliquis and Pradaxa.

However, Xarelto has been in the news for all the wrong reasons lately. Last fall, a report indicated a major safety study of the drug was tainted due to a malfunctioning test device. Then, reports surfaced that the manufacturers were complicit in keeping the missing data from a major medical journal.

Read More

FDA Recalls & Warnings - Gordon Food Service, ConAgra, Tippin's Gourmet Pies

Tuesday, July 26, 2016

The FDA announced a recall by Krispak, Inc. of their Gordon Food Service (GFS) brand of Honey Roasted Peanuts based on the undisclosed presence of pecans in some packages, which may cause aggravation of food allergies in some users.

Agave Dream issued a recall of its Cappuccino Ice Cream brand based on the possible presence of listeria monocytogenes. Listeria is an infection that can cause symptoms ranging from mild to severe, and even death in young children or the elderly.

Read More

prev 1 2 3 4 5 6 7 8 9 10 next